Medtronic (MDT) Cash & Equivalents Growth (1y) (2014 - 2026)

Medtronic (MDT) Cash & Equivalents Growth (1y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 4.15%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 24.05%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -12.13%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -22.13%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 23.57%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -7.71%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -10.02%
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 141.82%
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn 156.03%

Historic Data

Download Data
DateValue
Apr 24, 2026 -12.13%
Jan 23, 2026 -7.50%
Oct 24, 2025 -8.03%
Jul 25, 2025 -2.90%
Apr 25, 2025 72.74%
Jan 24, 2025 -23.60%
Oct 25, 2024 6.33%
Jul 26, 2024 -2.09%
Apr 26, 2024 -16.79%
Jan 26, 2024 -64.10%
Oct 27, 2023 -72.85%
Jul 28, 2023 -37.43%
Apr 28, 2023 -58.45%
Jan 27, 2023 29.95%
Oct 28, 2022 66.48%
Jul 29, 2022 -28.76%
Apr 29, 2022 3.37%
Jan 28, 2022 -31.48%
Oct 29, 2021 -54.83%
Jul 30, 2021 -53.78%